CCL18: a potential immunosuppressive biomarker for prognosis in ABC diffuse large B-cell lymphoma.
Saved in:
| Title: | CCL18: a potential immunosuppressive biomarker for prognosis in ABC diffuse large B-cell lymphoma. |
|---|---|
| Authors: | Rodríguez M; Pathology Department, Fundación Jiménez Díaz University Hospital, Madrid, Spain., Rojas-Vega F; Department of Genetics, University of Cordoba, Maimonides Biomedical Research Institute of Cordoba (IMIBIC), Reina Sofía University Hospital, Córdoba, Spain., Díaz-Alejo JF; Pathology Department, Fundación Jiménez Díaz University Hospital, Madrid, Spain., Mahillo-Fernández I; Bioestatistics and Epidemiology Unit, Instituto de Investigación Sanitaria-Fundación Jiménez Díaz University Hospital, Madrid, Spain., Serrano C; Immunology department, Fundación Jiménez Díaz University Hospital, UAM, Madrid, Spain., López A; Hematology Department, Fundación Jiménez Díaz University Hospital, Universidad Autónoma of Madrid (UAM), Madrid, Spain., Morales-Ruiz T; Department of Genetics, University of Cordoba, Maimonides Biomedical Research Institute of Cordoba (IMIBIC), Reina Sofía University Hospital, Córdoba, Spain., Roldan-Arjona T; Department of Genetics, University of Cordoba, Maimonides Biomedical Research Institute of Cordoba (IMIBIC), Reina Sofía University Hospital, Córdoba, Spain., Sánchez-García J; Hematology Department, Reina Sofía University Hospital/Maimonides Biomedical Research Institute of Córdoba (IMIBIC)/University of Córdoba, Córdoba, Spain., Río-Machín A; Experimental Hematology Lab, Instituto de Investigación Sanitaria (IIS)-Fundación Jiménez Díaz, UAM, Madrid, Spain.; Centre for Haemato-Oncology, Barts Cancer Institute, Queen Mary University of London, London, United Kingdom., Morillo D; Hematology Department, Fundación Jiménez Díaz University Hospital, Universidad Autónoma of Madrid (UAM), Madrid, Spain., Pérez MA; Hematology Department, Fundación Jiménez Díaz University Hospital, Universidad Autónoma of Madrid (UAM), Madrid, Spain., Córdoba R; Hematology Department, Fundación Jiménez Díaz University Hospital, Universidad Autónoma of Madrid (UAM), Madrid, Spain.; Experimental Hematology Lab, Instituto de Investigación Sanitaria (IIS)-Fundación Jiménez Díaz, UAM, Madrid, Spain., Llamas-Sillero P; Hematology Department, Fundación Jiménez Díaz University Hospital, Universidad Autónoma of Madrid (UAM), Madrid, Spain.; Experimental Hematology Lab, Instituto de Investigación Sanitaria (IIS)-Fundación Jiménez Díaz, UAM, Madrid, Spain., Rodríguez-Pinilla SM; Pathology Department, Fundación Jiménez Díaz University Hospital, Madrid, Spain., Serrano-López J; Experimental Hematology Lab, Instituto de Investigación Sanitaria (IIS)-Fundación Jiménez Díaz, UAM, Madrid, Spain.; Facultad de Biomedicina, Universidad Alfonso X el Sabio (UAX), Villanueva de la Cañada, Spain. |
| Source: | Frontiers in immunology [Front Immunol] 2025 Dec 15; Vol. 16, pp. 1693730. Date of Electronic Publication: 2025 Dec 15 (Print Publication: 2025). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1664-3224 |
|---|---|
| DOI: | 10.3389/fimmu.2025.1693730 |
